We know all we need to know about lenzilumab's safety and efficacy. We reported the LIVE-AIR trial results. Soon, the PREACH-M trial results will also be published, and based on the interim results, we know that will lead to Australian approval and other regulatory incentives, to include a PRV.
I recall that it was 300K doses we had to trash, because the product reached the expiration date. I also know that other manufacturers got extensions of the arbitrary expiration dates.
Management will succeed in getting lenz approved. Management will accomplish this overseas, and that will lead to US authorization, especially if HIVICRON proves to be more lethal than anything we have yet seen. I only hope that lenz will be able to help to restore the innate immune response system, which has been severely damaged by the mRNA vaccines.